Sensus Healthcare (SRTS)
(Delayed Data from NSDQ)
$5.80 USD
-0.11 (-1.86%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $5.77 -0.03 (-0.52%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth D Momentum C VGM
Income Statements
Fiscal Year end for Sensus Healthcare, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 24 | 45 | 27 | 10 | 27 |
Cost Of Goods | 10 | 15 | 10 | 4 | 10 |
Gross Profit | 14 | 30 | 17 | 5 | 18 |
Selling & Adminstrative & Depr. & Amort Expenses | 14 | 15 | 13 | 13 | 20 |
Income After Depreciation & Amortization | 0 | 15 | 4 | -8 | -2 |
Non-Operating Income | 1 | 13 | 0 | 1 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 1 | 28 | 4 | -7 | -2 |
Income Taxes | 0 | 4 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 0 | 24 | 4 | -7 | -2 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 0 | 24 | 4 | -7 | -2 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 15 | 5 | -8 | -1 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 1 | 1 | 1 |
Income After Depreciation & Amortization | 0 | 15 | 4 | -8 | -2 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 16.27 | 16.62 | 16.50 | 16.43 | 16.32 |
Diluted EPS Before Non-Recurring Items | 0.03 | 0.69 | 0.25 | -0.42 | -0.10 |
Diluted Net EPS (GAAP) | 0.03 | 1.46 | 0.25 | -0.42 | -0.10 |
Fiscal Year end for Sensus Healthcare, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 9.24 | 10.66 | 12.57 | 3.90 | 4.53 |
Cost Of Goods | 3.82 | 4.00 | 4.74 | 1.91 | 1.91 |
Gross Profit | 5.42 | 6.66 | 7.83 | 1.99 | 2.62 |
SG&A, R&D, and Dept/Amort Expenses | 3.45 | 3.78 | 2.26 | 3.88 | 3.74 |
Income After SG&A, R&D, and Dept/Amort Expenses | 1.97 | 2.88 | 5.57 | -1.89 | -1.12 |
Non-Operating Income | 0.21 | 0.21 | 0.23 | 0.32 | 0.25 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 2.19 | 3.10 | 5.81 | -1.58 | -0.88 |
Income Taxes | 0.58 | 0.83 | 1.60 | -0.13 | -0.50 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 1.61 | 2.27 | 4.21 | -1.45 | -0.38 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 1.61 | 2.27 | 4.21 | -1.45 | -0.38 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 16.33 | 16.32 | 16.27 | 16.27 | 16.25 |
Diluted EPS Before Non-Recurring Items | 0.10 | 0.14 | 0.26 | -0.09 | -0.02 |
Diluted Net EPS (GAAP) | 0.10 | 0.14 | 0.26 | -0.09 | -0.02 |